BRYAN BALL - 11 Jan 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
Chief Qual. Officer & SVP Ops.
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
-$41,318
Form type
4
Filing time
13 Jan 2022, 18:04:40 UTC
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $41,318 -2,455 -9.8% $16.83 22,545 11 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney